Home Supplements A to Z Research Newsletter About Us Contact Us

Supplement Safety Dietary Supplement Alerts and Safety Information Using Dietary Supplements Wisely The Dietary Supplements Labels Database Annual Bibliographies of Significant Advances in Dietary Supplement Research Tips for Older Dietary Supplement Users



SAMe Research Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. S-adenosyl-l-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry. Long-term treatment with S-adenosylmethionine induces changes in presynaptic CaM kinase II and synapsin I. Double-blind, placebo-controlled study of S-adenosyl-L-methionine in depressed postmenopausal women.



  

Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us

Copyright ©2009 Viteva